Reticulocyte hemoglobin content

American Journal of Hematology

Volumn 83, Issue 4, 2008, Pages 307-310

  Mast, Alan E ^a   Blinder, Morey A ^b   Dietzen, Dennis J ^b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; IRON;

ARTICLE; DIAGNOSTIC TEST; ERYTHROPOIESIS; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; PRIORITY JOURNAL; RETICULOCYTE HEMOGLOBIN CONTENT;

ADULT; ANEMIA; ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; ERYTHROPOIESIS; ERYTHROPOIETIN; HEMOGLOBINOMETRY; HUMANS; IRON; NEPHELOMETRY AND TURBIDIMETRY; RETICULOCYTES; SENSITIVITY AND SPECIFICITY;

EID: 41449106883     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21090     Document Type: Article

References (25)

1. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deticiency. Clin Chem 2002;48:1066-1076.
2. Guyatt GH, Oxman AD, Ali M, et al. Laboratory diagnosis of iron-deficiency anemia: An overview. J Gen Intern Med 1992;7:145-153.
3. Mast AE, Blinder MA, Lu Q, et al. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002;99:1489-1491.
4. Markovic M, Majkic-Singh N, Subota V. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease. Scand J Clin Lab Invest 2005;65:571-576.
5. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-1057.
6. Mohandas N, Kim YR, Tycko DH, et al. Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. Blood 1986;68:506-513.
7. Buttarello M, Temporin V, Ceravolo R, et al. The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: Its use in the diagnosis and monitoring of posttreatment sideropenic anemia. Am J Clin Pathol 2004;121:489-495.
8. Thomas L, Franck S, Messinger M, et al. Reticulocyte hemoglobin measurement - comparison of two methods in the diagnosis of iron-restricted erythropoiesis. Clin Chem Lab Med 2005;43:1193-1202.
9. David O, Grillo A, Ceoloni B, et al. Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease. Scand J Clin Lab Invest 2006;66:113-120.
10. Brugnara C, Schiler B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol 2006;28:303-308.
11. Brugnara C, Zurakowski D, DiCanzio J, et al. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA 1999;281:2225-2230.
12. Ullrich C, Wu A, Armsby C, et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA 2005;294:924-930.
13. Bakr AF, Sarette G. Measurement of reticulocyte hemoglobin content to diagnose iron deficiency in Saudi children. Eur J Pediatr 2006;165:442-445.
14. Roy CN, Mak HH, Akpan I, et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 2007;109:4038-4044.
15. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Ann Rev Nutr 2006;26:323-342.
16. Kopelman RC, Smith L, Peoples L, et al. Functional iron deficiency in hemodialysis patients with high ferritin. Hemodial Int 2007;11:238-246.
17. Fishbane S, Shapiro W, Dutka P, et al. A randomized trial of iron deficiency testing strategies in hemodialysis patients1. Kidney Int 2001;60;2406-2411.
18. Mittman N, Sreedhara R, Mushnick R, et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997;30:912-922.
19. Tsuchiya K, Okano H, Teramura M, et al. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients. Clin Nephrol 2003;59:115-123.
20. Chuang CL, Liu RS, Wei YH, et al. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant 2003;18:370-377.
21. Brugnara C. Iron deficiency and erythropoiesis: New diagnostic approaches. Clin Chem 2003;49:1573-1578.
22. Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 2003;4:459-460.
23. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet 2003;362:1255-1260.
24. Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-2098.
25. Skarmoutsou C, Papassotiriou I, Traeger-Synodinos J, et al. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels. Haematologica 2003;88:631-636.